Barclays Maintains Equal-Weight on Revance Therapeutics, Lowers Price Target to $3

Benzinga2024/12/23 20:43

Revance Therapeutics Ticks Higher as Holder Says Crown Deal Undervalues Company

Seeking Alpha2024/12/19 23:10

Key Deals for the Week: Patterson, Hershey & Mondelez, AIG & Nippon and More

Seeking Alpha2024/12/14 21:25

Shareholder Alert: Ademi LLP Investigates Whether Revance Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Businesswire2024/12/13 00:30

Revance Therapeutics Board Recommends Stockholders Tender Shares to Crown Laboratories

MT Newswires2024/12/12 23:55

Revance Therapeutics Board of Directors Recommend Stockholders Tender Their Shrs >RVNC

Dow Jones2024/12/12 21:02